Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Clinical Research

Computed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer

Prostate Cancer and Prostatic Diseases volume 18, pages 155–160 (2015)Cite this article

Subjects

Abstract

Background:

To evaluate whether very high b-value computed diffusion-weighted imaging (cDWI) is able to provide better contrast between the foci of prostate cancer and background tissue than the standard apparent diffusion coefficient (ADC) map, and whether this improved contrast could be used to improve the tumor detection.

Methods:

Very high b-value cDWI series up to b4000 were created for 14 patients with high-grade prostate cancer. Contrast-to-noise ratios (CNRs) and CNR-to-ADC ratios were calculated. Three blinded readers also assessed the tumor conspicuity on a standard five-point scale.

Results:

The tumor CNR increased with increasing b-values in all the patients up to a maximum average CNR of 75.1 for a b-value of 4000 (average CNR for the ADC maps: 10.0). CNR/ADC ratios were higher than 1 (indicating higher CNR than respective ADC) for cDWI of 1500 and higher, with a maximum of 6.5 for cDWI4000. The average subjective tumor conspicuity scores for cDWI2000, 3000 and 4000 were significantly higher than that of the ADC (4.0): 4.5 (P=0.018), 4.5 (P=0.017) and 4.6 (P=0.012).

Conclusions:

cDWI is able to provide better contrast between the foci of prostate cancer and background tissue compared with a standard ADC map. This resulted in improved subjective tumor conspicuity.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Gupta RT, Kauffman CR, Polascik TJ, Taneja SS, Rosenkrantz AB . The state of prostate MRI in 2013. Oncology (Williston Park) 2013; 27: 262–270.

    Google Scholar 

  2. Tan CH, Wei W, Johnson V, Kundra V . Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol 2012; 199: 822–829.

    Article  PubMed  PubMed Central  Google Scholar 

  3. McNeal JE, Redwine EA, Freiha FS, Stamey TA . Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988; 12: 897–906.

    Article  CAS  PubMed  Google Scholar 

  4. Koh DM, Collins DJ . Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622–1635.

    Article  PubMed  Google Scholar 

  5. Le Bihan D, Poupon C, Amadon A, Lethimonnier F . Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging 2006; 24: 478–488.

    Article  PubMed  Google Scholar 

  6. Blackledge MD, Leach MO, Collins DJ, Koh DM . Computed diffusion-weighted MR imaging may improve tumor detection. Radiology 2011; 261: 573–581.

    Article  PubMed  Google Scholar 

  7. Rosset A, Spadola L, Ratib O . OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging 2004; 17: 205–216.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 2011; 59: 477–494.

    Article  PubMed  Google Scholar 

  9. Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T et al. Multiparametric 3 T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011; 186: 1818–1824.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Riches SF, Payne GS, Morgan VA, Sandhu S, Fisher C, Germuska M et al. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters. AJR Am J Roentgenol 2009; 193: 1583–1591.

    Article  PubMed  Google Scholar 

  11. Maas MC, Futterer JJ, Scheenen TW . Quantitative evaluation of computed high b value diffusion-weighted magnetic resonance imaging of the prostate. Invest Radiol 2013; 48: 779–786.

    Article  PubMed  Google Scholar 

  12. Bomers JG, Barentsz JO . Standardization of multiparametric prostate MR imaging using PI-RADS. Biomed Res Int 2014; 2014: 431680.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Rosenkrantz AB, Chandarana H, Hindman N, Deng FM, Babb JS, Taneja SS et al. Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection. Eur Radiol 2013; 23: 3170–3177.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology & Medical Imaging, University of Virginia Health System, Charlottesville, VA, USA

    S Feuerlein & A Krishnaraj

  2. Department of Radiology, University of Michigan Health System, Ann Arbor, MI, USA

    M S Davenport

  3. Department of Radiology, University of Basel, Basel, Switzerland

    E M Merkle

  4. Department of Radiology, Duke University Medical Center DUMC, Durham, NC, USA

    R T Gupta

Authors
  1. S Feuerlein
    View author publications

    Search author on:PubMed Google Scholar

  2. M S Davenport
    View author publications

    Search author on:PubMed Google Scholar

  3. A Krishnaraj
    View author publications

    Search author on:PubMed Google Scholar

  4. E M Merkle
    View author publications

    Search author on:PubMed Google Scholar

  5. R T Gupta
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to S Feuerlein.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feuerlein, S., Davenport, M., Krishnaraj, A. et al. Computed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer. Prostate Cancer Prostatic Dis 18, 155–160 (2015). https://doi.org/10.1038/pcan.2015.5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/pcan.2015.5

This article is cited by

Search

Advanced search

Quick links